 |
 Research |
|
Research APS intends to develop its technology platform by maintaining an active pipeline of products. It is achieving this through in-house research and collaborations with other companies and academia. APS does not intend to commercialise any of its products by itself but will develop them to at least to early stage proof of concept clinical trials. Product Pipeline in wound care APS will concentrate primarily on expanding its wound healing products in the following areas:- • Control of Infection • Control of Pain • Control of Odour • Treatment of Chronic Surgery and Trauma wounds (including platelet enhancers) • Treatment of malignant wounds • Use of recombinant products |
|
| ©
Advanced Protein Systems 2006 | Site Map
| Privacy | Links
|
|